Autophagy prevents doxorubicin-induced apoptosis in osteosarcoma

Molecular Medicine Reports

Volumn 9, Issue 5, 2014, Pages 1975-1981

  Zhao, Dongxu ^a   Yuan, Hongping ^a   Yi, Fei ^a   Meng, Chunyang ^a   Zhu, Qingsan ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Apoptosis; Autophagy; Doxorubicin; Osteosarcoma

Indexed keywords

3 METHYLADENINE; AUTOPHAGY RELATED PROTEIN 7; CASPASE 3; CYTOCHROME C; DOXORUBICIN; MICROTUBULE ASSOCIATED PROTEIN 1; PROTEIN; PROTEIN P62; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; AUTOPHAGY; CELL GROWTH; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; LIGHT CHAIN; MITOCHONDRIAL MEMBRANE POTENTIAL; OSTEOSARCOMA; SAOS 2 CELL LINE; U2OS CELL LINE; WESTERN BLOTTING;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; AUTOPHAGY; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; HUMANS; OSTEOSARCOMA; RNA, SMALL INTERFERING; UBIQUITIN-ACTIVATING ENZYMES;

EID: 84899512023     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2055     Document Type: Article

References (28)

1. Chou AJ, Merola PR, Wexler LH, et al: Treatment of osteosarcoma at first recurrence after contemporary therapy: the Memorial Sloan-Kettering Cancer Center experience. Cancer 104: 2214-2221, 2005.
2. Nakase M, Inui M, Okumura K, Kamei T, Nakamura S and Tagawa T: p53 gene therapy of human osteosarcoma using a transferrin-modified cationic liposome. Mol Cancer Ther 4: 625-631, 2005.
3. Janeway KA and Grier HE: Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects. Lancet Oncol 11: 670-678, 2010.
4. Yang Z and Klionsky DJ: Eaten alive: a history of macroautophagy. Nat Cell Biol 12: 814-822, 2010.
5. Klionsky DJ: The molecular machinery of autophagy: unanswered questions. J Cell Sci 118: 7-18, 2005.
6. Levine B and Klionsky DJ: Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 6: 463-477, 2004.
7. Mizushima N: The pleiotropic role of autophagy: from protein metabolism to bactericide. Cell Death Differ 12 (Suppl 2): 1535-1541, 2005.
8. Rubinsztein DC, Gestwicki JE, Murphy LO and Klionsky DJ: Potential therapeutic applications of autophagy. Nat Rev Drug Discov 6: 304-312, 2007.
9. Huang WP and Klionsky DJ: Autophagy in yeast: a review of the molecular machinery. Cell Struct Funct 27: 409-420, 2002.
10. Luo S and Rubinsztein DC: Apoptosis blocks Beclin 1-dependent autophagosome synthesis: an effect rescued by Bcl-xL. Cell Death Differ 17: 268-277, 2010.
11. Del Bello B, Toscano M, Moretti D and Maellaro E: Cisplatin-induced apoptosis inhibits autophagy, which acts as a pro-survival mechanism in human melanoma cells. PLoS One 8: e57236, 2013.
12. Hippert MM, O'Toole PS and Thorburn A: Autophagy in cancer: good, bad, or both? Cancer Res 66: 9349-9351, 2006.
13. Thorburn A: Apoptosis and autophagy: regulatory connections between two supposedly different processes. Apoptosis 13: 1-9, 2008.
14. Djavaheri-Mergny M, Maiuri MC and Kroemer G: Cross talk between apoptosis and autophagy by caspase-mediated cleavage of Beclin 1. Oncogene 29: 1717-1719, 2010.
15. Hou W, Han J, Lu C, Goldstein LA and Rabinowich H: Autophagic degradation of active caspase-8: a crosstalk mechanism between autophagy and apoptosis. Autophagy 6: 891-900, 2010.
16. Lowe SW, Ruley HE, Jacks T and Housman DE: p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957-967, 1993.
17. Yu R, Shtil AA, Tan TH, Roninson IB and Kong AN: Adriamycin activates c-jun N-terminal kinase in human leukemia cells: a relevance to apoptosis. Cancer Lett 107: 73-81, 1996.
18. Spina A, Sorvillo L, Di Maiolo F, et al: Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway. J Cell Physiol 228: 198-206, 2013.
19. Gill J, Ahluwalia MK, Geller D and Gorlick R: New targets and approaches in osteosarcoma. Pharmacol Ther 137: 89-99, 2013.
20. Radetzki S, Köhne CH, von Haefen C, et al: The apoptosis promoting Bcl-2 homologues Bak and Nbk/Bik overcome drug resistance in Mdr-1-negative and Mdr-1-overexpressing breast cancer cell lines. Oncogene 21: 227-238, 2002.
21. Tarquini F, Tiribuzi R, Crispoltoni L, et al: Caspase 3 activation and PARP cleavage in lymphocytes from newborn babies of diabetic mothers with unbalanced glycaemic control. Cell Biochem Funct 32: 87-95, 2014.
22. Fong MY, Jin S, Rane M, Singh RK, Gupta R and Kakar SS: Withaferin A synergizes the therapeutic effect of doxorubicin through ROS-mediated autophagy in ovarian cancer. PLoS One 7: e42265, 2012.
23. Li H, Jin X, Zhang Z, Xing Y and Kong X: Inhibition of autophagy enhances apoptosis induced by the PI3K/AKT/mTor inhibitor NVP-BEZ235 in renal cell carcinoma cells. Cell Biochem Funct 31: 427-433, 2013.
24. Kabeya Y, Mizushima N, Ueno T, et al: LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 19: 5720-5728, 2000.
25. Kang R, Zeh HJ, Lotze MT and Tang D: The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ 18: 571-580, 2011.
26. Zhong JT, Xu Y, Yi HW et al: The BH3 mimetic S1 induces autophagy through ER stress and disruption of Bcl-2/Beclin 1 interaction in human glioma U251 cells. Cancer Lett 323: 180-187, 2012.
27. Chang Z, Shi G, Jin J, et al: Dual PI3K/mTOR inhibitor NVP-BEZ235-induced apoptosis of hepatocellular carcinoma cell lines is enhanced by inhibitors of autophagy. Int J Mol Med 31: 1449-1456, 2013.
28. Fimia GM and Piacentini M: Regulation of autophagy in mammals and its interplay with apoptosis. Cell Mol Life Sci 67: 1581-1588, 2010.